Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Ravi B. Parikh; Blythe J.S. Adamson; Sean Khozin; Matthew D. Galsky; Shrujal S. Baxi; Aaron Cohen; Ronac Mamtani

doi:10.1001/jama.2019.10650

Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Ravi B. Parikh
, Blythe J.S. Adamson
, Sean Khozin
, Matthew D. Galsky
, Shrujal S. Baxi
, Aaron Cohen
, Ronac Mamtani

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	1209-1211
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	12
DOIs	https://doi.org/10.1001/jama.2019.10650
State	Published - 24 Sep 2019

Access to Document

10.1001/jama.2019.10650

Cite this

@article{ab501edb12db431a88c5ad5fba73907c,

title = "Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer",

author = "Parikh, \{Ravi B.\} and Adamson, \{Blythe J.S.\} and Sean Khozin and Galsky, \{Matthew D.\} and Baxi, \{Shrujal S.\} and Aaron Cohen and Ronac Mamtani",

note = "Funding Information: Conflict of Interest Disclosures: Dr Eikermann reported receiving unrestricted funds from philanthropic donors Jeffrey and Judy Buzen and grants from Merck. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by grants from the Conquer Cancer Foundation (Dr Parikh) and grants 5-T32-CA009615 (Dr Parikh) and K23-CA187185 (Dr Mamtani) from the National Cancer Institute of the National Institutes of Health.",

year = "2019",

month = sep,

day = "24",

doi = "10.1001/jama.2019.10650",

language = "English",

volume = "322",

pages = "1209--1211",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

AU - Parikh, Ravi B.

AU - Adamson, Blythe J.S.

AU - Khozin, Sean

AU - Galsky, Matthew D.

AU - Baxi, Shrujal S.

AU - Cohen, Aaron

AU - Mamtani, Ronac

N1 - Funding Information: Conflict of Interest Disclosures: Dr Eikermann reported receiving unrestricted funds from philanthropic donors Jeffrey and Judy Buzen and grants from Merck. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by grants from the Conquer Cancer Foundation (Dr Parikh) and grants 5-T32-CA009615 (Dr Parikh) and K23-CA187185 (Dr Mamtani) from the National Cancer Institute of the National Institutes of Health.

PY - 2019/9/24

Y1 - 2019/9/24

UR - https://www.scopus.com/pages/publications/85072561176

U2 - 10.1001/jama.2019.10650

DO - 10.1001/jama.2019.10650

M3 - Letter

C2 - 31550019

AN - SCOPUS:85072561176

SN - 0098-7484

VL - 322

SP - 1209

EP - 1211

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 12

ER -